| Literature DB >> 34547466 |
Min Li1, Yuxiao Tang2, Dongyao Wang3, Xiaofeng Zhai4, Hui Shen2, Chen Zhong5, Man Yao4, Aiguo Jin4, Zhengjun Zhou6, Shaolai Zhou6, Jia Fan6, Chang-Quan Ling7, Chen Ling8.
Abstract
Iron dyshomeostasis is associated with hepatocellular carcinoma (HCC) development. However, the role of iron in HCC metastasis is unknown. This study aimed to elucidate the underlying mechanisms of iron's enhancement activity on HCC metastasis. In addition to the HCC cell lines and clinical samples in vitro, iron-deficient (ID) mouse models were generated using iron-free diet and transferrin receptor protein knockout, followed by administration of HCC tumors through either orthotopic or ectopic route. Clinical metastatic HCC samples showed significant ID status, accompanied by overexpression of sphingosine-1-phosphate transporter spinster homolog 2 (SPNS2). Mechanistically, ID increased SPNS2 expression, leading to HCC metastasis in both cell cultures and mouse models. ID not only altered the anti-tumor immunity, which was indicated by phenotypes of lymphatic subsets in the liver and lung of tumor-bearing mice, but also promoted HCC metastasis in a cancer cell autonomous manner through the SPNS2. Since germline knockout of globe SPNS2 showed significantly reduced HCC metastasis, we further developed hepatic-targeting recombinant adeno-associated virus vectors to knockdown SPNS2 expression and to inhibit iron-regulated HCC metastasis. Our observation indicates the role of iron in HCC pulmonary metastasis and suggests SPNS2 as a potential therapeutic target for the prevention of HCC pulmonary metastasis.Entities:
Keywords: adeno-associated viral vectors; hepatocellular carcinoma; iron deficiency; metastasis; sphingosine-1-phosphate transporter spinster homolog 2
Mesh:
Substances:
Year: 2021 PMID: 34547466 PMCID: PMC8821935 DOI: 10.1016/j.ymthe.2021.09.012
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454